Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

New radiopharmaceutical to be trialed as prostate cancer therapy

The radiopharmaceutical, I-131-MIP-1466, which is designed to deliver a therapeutic dose of radiation to metastatic prostate cancer, will enter a clinical trial to evaluate its efficacy and benefits for patients.

Mylan nets FDA approval to market generic Lipitor

Mylan's subsidiary Mylan Laboratories Limited (formerly Matrix Laboratories Limited) has received tentative approval from the FDA for its abbreviated New Drug Application for atorvastatin calcium tablets.

Merck's combo type 2 diabetes drug gets FDA thumbs up

The FDA has approved Merck's Janumet XR (sitagliptin and metformin hydrochloride extended-release) tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of Januvia (sitagliptin), with extended-release metformin.

CMS recommends coverage for TAVR, with stipulations

The Centers for Medicare & Medicaid Services (CMS) today proposed that coverage for transcatheter aortic valve replacement (TAVR) be approved under coverage with evidence development (CED) for certain conditions.

JACR: If you build it, they will comeImaging CPOE gains acceptance

Computerized physician order entry (CPOE) of imaging orders has the potential to improve healthcare efficiency, safety and cost-effectiveness, but only if clinicians get behind implementation of such systems. That might not be a problem, however, as an imaging CPOE system with embedded decision support can be broadly accepted clinically, according to a 10-year study of CPOE use at a large, university-affiliated facility published in the February issue of the Journal of the American College of Radiology.

MGMA to HHS: Delay 5010 enforcement

The mandated Jan. 1 conversion to a new set of electronic claims transaction standards is not going smoothly for office-based physicians, disrupting medical groups' cash flow and creating hassles, according to the head of the Medical Group Management Association (MGMA)-American College of Medical Practice Executives (ACMPE).

NEJM: Chemo without rad therapy improves Hodgkins survival rate

Chemotherapy alone has been shown to be an effective treatment for Hodgkins lymphoma, with a higher rate of overall survival than a treatment strategy combining chemotherapy with radiation therapy, according to a study published in the Feb. 2 edition of the New England Journal of Medicine.

Cash, recognition await winners of healthcare technology management competition

Healthcare Technology Management magazine has issued a call for entries in its new workplace-performance competition, the Best Practices in Healthcare Technology Management Awards.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.